30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Rowe Co (ROW)

Track

Stock chart
Ticker: ROW
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
MORPHIS GENE S
Chief Financial Officer
2 purchases — total 32,104 USD
Buy 28 Sep 2005
Value US$4,599,233.97 | Price 317.35 | Shares 33,795
Buy 28 Sep 2005
Value US$2,558,013.17 | Price 490.37 | Shares 93,523
Buy 26 Sep 2005
Value US$3,212,475.48 | Price 392.87 | Shares 85,964
Buy 8 Jul 2005
Value US$390.00 | Price 3.90 | Shares 100
Buy 7 Jul 2005
Value US$2,304.00 | Price 3.84 | Shares 600
Buy 7 Jul 2005
Value US$9,500.00 | Price 3.80 | Shares 2,500
Buy 25 Mar 2004
Value US$17,390.00 | Price 3.70 | Shares 4,700
Buy 25 Mar 2004
Value US$1,107.00 | Price 3.69 | Shares 300
Sale 21 Jan 2004
Value US$15,300.00 | Price 6.00 | Shares 2,550
Sale 21 Jan 2004
Value US$29,750.00 | Price 5.95 | Shares 5,000
Sale 20 Jan 2004
Value US$3,000.00 | Price 6.00 | Shares 500
Sale 16 Jan 2004
Value US$9,015.00 | Price 6.01 | Shares 1,500
Sale 16 Jan 2004
Value US$235,200.00 | Price 6.00 | Shares 39,200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2005-09-29 2005-09-28 B Purchase MORPHIS GENE S

Chief Financial Officer

Officer
33,795 +47.9%
317.35
US$4,599,234 		33,795 +47.9% 317.35 US$4,599,234
2005-09-29 2005-09-28 B Purchase MORPHIS GENE S

Chief Financial Officer

Officer
93,523 +19.8%
490.37
US$2,558,013 		93,523 +19.8% 490.37 US$2,558,013
2005-09-29 2005-09-26 B Purchase FORTUNE TIMOTHY J

Vice President/Strategy/HR

Officer
85,964 -24.6%
392.87
US$3,212,475 		85,964 -24.6% 392.87 US$3,212,475
2005-07-08 2005-07-08 B Purchase MORPHIS GENE S

Chief Financial Officer

Officer
100 +0.3%
3.90
US$390 		100 +0.3% 3.90 US$390
2005-07-08 2005-07-07 B Purchase MORPHIS GENE S

Chief Financial Officer

Officer
600 +1.7%
3.84
US$2,304 		600 +1.7% 3.84 US$2,304
2005-07-08 2005-07-07 B Purchase MORPHIS GENE S

Chief Financial Officer

Officer
2,500 +7.6%
3.80
US$9,500 		2,500 +7.6% 3.80 US$9,500
2004-03-25 2004-03-25 B Purchase MORPHIS GENE S

Chief Financial Officer

Officer
4,700 +25.7%
3.70
US$17,390 		4,700 +25.7% 3.70 US$17,390
2004-03-25 2004-03-25 B Purchase MORPHIS GENE S

Chief Financial Officer

Officer
300 +1.7%
3.69
US$1,107 		300 +1.7% 3.69 US$1,107
2004-01-21 2004-01-21 S Sale PTASHEK HARVEY I Non-Executive Director
2,550 -100.0%
6.00
US$15,300 		2,550 -100.0% 6.00 US$15,300
2004-01-21 2004-01-21 S Sale PTASHEK HARVEY I Non-Executive Director
5,000 -66.2%
5.95
US$29,750 		5,000 -66.2% 5.95 US$29,750
2004-01-20 2004-01-20 S Sale PTASHEK HARVEY I Non-Executive Director
500 -6.2%
6.00
US$3,000 		500 -6.2% 6.00 US$3,000
2004-01-16 2004-01-16 S Sale PTASHEK HARVEY I Non-Executive Director
1,500 -15.7%
6.01
US$9,015 		1,500 -15.7% 6.01 US$9,015
2004-01-16 2004-01-16 S Sale PTASHEK HARVEY I Non-Executive Director
39,200 -80.4%
6.00
US$235,200 		39,200 -80.4% 6.00 US$235,200
Explore more

More insider trading research around Rowe Co

More insider trades in United States
Insider trading in North America